David A. Fishman

14.8k citations

157 papers · 11.4k indexed · 2 hit papers · h-index 53

Impact in

Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
Cancer Research top 0.5%
- Protease and Inhibitor Mechanisms

Papers in

Reproductive Medicine 48
- Ovarian cancer diagnosis and treatment 47
Cancer Research 32
- Protease and Inhibitor Mechanisms 19

Co-authors: Lance A. Liotta Gordon B. Mills Emanuel F. Petricoin Vincent A. Fusaro M. Sharon Stack Seth M. Steinberg Elise C. Kohn Ben A. Hitt
Journals: Gynecologic Oncology (28 papers)Cancer Research (7 papers)Obstetrics and Gynecology (5 papers)Cancer treatment and research (5 papers)American Journal of Obstetrics and Gynecology (4 papers)
Partner nations: United States Canada Japan

In The Last Decade

David A. Fishman

153 papers receiving 11.1k citations

Hit Papers

align trajectories log scale

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. 2002 · 502 citations

Peers

Countries citing papers authored by David A. Fishman

Since Specialization

Citations

This map shows the geographic impact of David A. Fishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Fishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Fishman more than expected).

Fields of papers citing papers by David A. Fishman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Fishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Fishman. The network helps show where David A. Fishman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David A. Fishman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Fishman Line = papers co-authored together David A. Fishman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complementary and alternative medicine therapies for the anesthesiologist and pain practitioner: a narrative review Canadian Journal of Anesthesia/Journal canadien d anesthésie ·Anna Woodbury, Stephen Neal Soong, David A. Fishman, Paul S. García	2015	8
2	Early Detection of Ovarian Cancer with Conventional and Contrast-Enhanced Transvaginal Sonography: Recent Advances and Potential Improvements Journal of Oncology ·Arthur C. Fleischer, Andrej Lyshchik, Ji Luan Chen Chen, Maritsa Hany, Richard G. Abramson, David A. Fishman	2012	13
3	The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC) Gynecologic Oncology ·Sonia Dutta, Fengqiang Wang, Haishan Wu, Álvaro Flores, David A. Fishman	2011	38
4	Biological Significance of Prolactin in Gynecologic Cancers Cancer Research ·Vera Levina, Brian M. Nolen, Семененко Наталья Александровна, Andrew K. Godwin, David A. Fishman, Jinsong Liu, Gil Mor, Larry G. Maxwell, Ronald B. Herberman, Mirosław J. Szczepański, Marta Szajnik, Elieser Gorelik, Anna Lokshin	2009	75
5	Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer Cancer Research ·Meera Nanjundan, Yasuhisa Nakayama, Kwai Wa Cheng, John Lahad, Jinsong Liu, Karen W. Lu, Wen-Lin Kuo, Karen Smith‐McCune, David A. Fishman, Joe W. Gray, Gordon B. Mills	2007	110
6	Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post‐translational modifications PROTEOMICS ·张凤清, Volodymyr OSTROVYI, Anwar Zahid, Linda J. Harvey, Paul Russo, Richard G. Saul, Mary F. Lopez, Alvydas Mikulskis, Scott Kuzdzal, Eva Golenko, David A. Fishman, Eric C. Vonderheid, Susan Booher, Edward W. Cowen, Sam T. Hwang, Gordon Whiteley	2007	14
7	Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays Cancer Research ·Madhumita Chatterjee, Saroj Kant Mohapatra, Alexei Ionan, G. Bawa, Rouba Ali‐Fehmi, Xiaoju Wang, Chen Bing-ya, Bin Ye, Fatimah A. Nahhas, Karen H. Lu, Steven S. Witkin, David A. Fishman, Adnan Munkarah, Robert Morris, Nancy K. Levin, T. Karimi, Gerard Tromp, Judith Abrams, Sorin Drăghici, Michael A. Tainsky	2006	165
8	Correlation of MMP-1 and PAR1 expression with epithelial ovarian cancer invasiveness Cancer Research ·Feng-Qiang Wang, M. Van Lint, David A. Fishman	2006	1
9	Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study The Lancet Oncology ·Esther M. John, Harvey A. Risch, Jan Lubiński, Pål Møller, Parviz Ghadirian, Henry T. Lynch, Beth Y. Karlan, David A. Fishman, Barry P. Rosen, Susan L. Neuhausen, Kenneth Offit, Noah D. Kauff, Susan M. Domchek, Nadine Tung, Eitan Friedman, William D. Foulkes, Ping Sun, Steven A. Narod	2006	154
10	High-resolution serum proteomic features for ovarian cancer detection. Endocrine Related Cancer ·Thomas P. Conrads, Vincent A. Fusaro, Sally Ross, Don Johann, Vinodh N. Rajapakse, Ben A. Hitt, Seth M. Steinberg, Elise C. Kohn, David A. Fishman, Suzanne Escudier, J. Carl Barrett, Lance A. Liotta, Emanuel F. Petricoin, Timothy D. Veenstra	2004	210
11	Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase International Journal of Cancer ·Feng-Qiang Wang, John So, Scott Reierstad, David A. Fishman	2004	156
12	Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. PubMed ·Andre T. Baron, Elsa M. Cora, Jacqueline M. Lafky, Cecelia H. Boardman, Helmut Nitsch, Alfred Rademaker, Dachao Liu, David A. Fishman, Karl C. Podratz, Nita J. Maihle	2003	82
13	Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy☆ Gynecologic Oncology ·Pedro F. Escobar, John R. Lurain, Diljeet K. Singh, Amina Ahmed Suraia Rahman, David A. Fishman	2003	72
14	Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature Gynecologic Oncology ·W. C. Shipley, Pedro F. Escobar, John R. Lurain, David A. Fishman	2003	17
15	Early Detection of Ovarian Cancer: Promise and Reality Cancer treatment and research ·Robert C. Bast, Nicole Urban, Viji Shridhar, Caroline Bulf, Zhen Zhang, Steven J. Skates, Karen H. Lu, Jinsong Liu, David A. Fishman, Gordon B. Mills	2002	109
16	BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer The American Journal of Human Genetics ·Roxana Moslehi, William Chu, Beth Y. Karlan, David A. Fishman, Harvey A. Risch, Abbie L. Fields, David Smotkin, Yehuda Ben‐David, Jacalyn Rosenblatt, Donna Russo, Peter E. Schwartz, Nadine Tung, Ellen Warner, Barry P. Rosen, Jan M. Friedman, Jean‐Sébastien Brunet, Steven A. Narod	2000	224
17	Cost-utility assessment of amifostine as first-line therapy for ovarian cancer International Journal of Gynecological Cancer ·C. L. Bennett, Robert Golub, Elizabeth A. Calhoun, Joanna Weinstein, David A. Fishman, John R. Lurain, F. A. Lee, Elmina Papatheodorou, Ronald M. Bukowski	1998	16
18	Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium Gynecologic Oncology ·David A. Fishman, Kenneth B. Roberts, Joseph T. Chambers, Ernest I. Kohorn, Peter E. Schwartz, Setsuko K. Chambers	1996	52
19	LAPAROSCOPIC HYSTERECTOMY AND PELVIC FLOOR RECONSTRUCTION Journal of Laparoendoscopic Surgery ·David A. Fishman, SABRINA BELLE	1996	10
20	Late Recurrences of Vaginal Clear Cell Adenocarcinoma Gynecologic Oncology ·David A. Fishman, Masaki FUCHI, William Small, Pacita Keh, Melvin V. Gerbie, Peter E. Schwartz, David M. Gershenson, John R. Lurain	1996	6

About David A. Fishman

David A. Fishman is a scholar working on Reproductive Medicine, Cancer Research, Obstetrics and Gynecology, Spectroscopy and Immunology and Allergy, having authored 157 papers that have together received 11.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (47 papers), Advanced Proteomics Techniques and Applications (22 papers), Protease and Inhibitor Mechanisms (19 papers), Sphingolipid Metabolism and Signaling (17 papers), Endometrial and Cervical Cancer Treatments (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Molecular Biology Techniques and Applications (9 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Reproductive Medicine (2.0k citations), Cancer Research (2.0k citations), Spectroscopy (2.2k citations), Molecular Biology (6.3k citations) and Obstetrics and Gynecology (683 citations). David A. Fishman has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Lance A. Liotta, Gordon B. Mills, Emanuel F. Petricoin, Vincent A. Fusaro, M. Sharon Stack, Seth M. Steinberg, Elise C. Kohn, Ben A. Hitt, Charles B. Simone and Ali M. Ardekani. Their work appears in journals such as Gynecologic Oncology, Cancer Research, Obstetrics and Gynecology, Cancer treatment and research and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact